Ahụ ike, Preparations
The ọgwụ maka ndị ikom "prostakor": ntuziaka maka ojiji
Description nke pharmacological edinam
Mgbe nile were "prostakor" nkwadebe (ntụziaka ntuziaka na-akwado) na-eme ka normalisation nke secretory ọrụ nke epithelial mkpụrụ ndụ, na-ebelata edema na leukocyte infiltration. Ọzọkwa, a na ọgwụ dị irè na-ebelata ihe ize ndụ nke thrombosis nke venules prostate. Ọzọkwa, nke a pụtara Organotropona akpali Akwara ụda nke ndị dị otú a ahu ka eriri afo na-enwekwu ndị ọdịnaya nke lecithin nsogbu dị iche iche na akpa ume secretions. Production ụlọ ọrụ na-ekwu na nke a ọgwụ nwere ihe e ji mara antiplatelet Njirimara.
Atụmatụ nke usoro onunu ogwu ụdị na mejupụtara nke ọgwụ ọjọọ
Egosi maka ojiji nke ọgwụ
Jiri ọgwụ "prostakor" ntụziaka na mbụ na-atụ aro maka ọgwụgwọ nke ala ala iche-iche nke prostatitis. Ọzọkwa, ifịk ifịk ọgwụ gosiri na ebe mgbe nsogbu mepụtara mgbe na-adịbeghị anya ịwa ahụ na prostate Gland onwe ya.
Scheme Ọnụọgụ ọgwụ na
Banyere ọgwụgwọ Usoro, na-atụ aro okenye ọrịa otu ugboro n'ụbọchị intramuscularly ndinọ 5-10 mg nke ọgwụ ọjọọ, "prostakor". Ọgwụ nke Council Regulation setịpụụrụ a kacha nta nke otu izu.
Na nke a, ma ọ bụrụ na ọ dị mkpa, a abụọ N'ezie nke ọgwụ nwere ike e kenyere ya, ma ọ bụghị tupu mgbe 1-6 ọnwa.
Isi contraindications ọgwụ
Mgbe itinye a Organotropona ọgwụ ọkachamara ike ịkwado nwoke ọrịa na-ata ahụhụ onye ekweghị ibe nọrọ wepụ nke anụmanụ prostate, ẹdude na a nkwadebe "prostakor". Ọgwụ (ndidi testimonials gosi ya) na-ekwesịghị itinye na ikpe nke adịghị anabata a glycine.
Similar articles
Trending Now